Tayahop, Roberto N.
HRN: 03-04-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
CEFTRIAXONE 1G (VIAL)
09/14/2023
09/20/2023
IV
2gm
Q24H
T/c Leptospirosis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes